| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-757 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C61-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
1997-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274bc7998c2c4d4a47281330ac13f10f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9872a3b37cd84cf3cafb30b594649de6 |
| publicationDate |
2000-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6100426-A |
| titleOfInvention |
Anti-viral compounds |
| abstract |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6908934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003125357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003086828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7312031-B1 |
| priorityDate |
1996-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |